REFERENCES
1. Huang M, Li J, Zhao X, Chen S, Li X, Jiang W. Relationship between vascular ageing and left ventricular geometry in patients with newly diagnosed primary aldosteronism. Front Endocrinol 2022;13:961882.
2. Pelà G, Tagliaferri S, Perrino F, et al. Determinants of cardiac structure in frail and sarcopenic elderly adults. Exp Gerontol 2021;150:111351.
3. Lembo M, Trimarco V, Izzo R, et al. Achieving a systolic blood pressure below 130 mmHg reduces the incidence of cardiovascular events in hypertensive patients with echocardiographic left ventricular hypertrophy. J Pharmacol Exp Ther 2023:388.
4. Maimaitiaili R, Teliewubai J, Zhao S, et al. Relationship between vascular aging and left ventricular concentric geometry in community-dwelling elderly: the northern shanghai study. Clin Interv Aging 2020;15:853-63.
5. Prasad A, Popovic ZB, Arbab-Zadeh A, et al. The effects of aging and physical activity on Doppler measures of diastolic function. Am J Cardiol 2007;99:1629-36.
6. Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004;110:1799-805.
7. van Ommen AMLN, Canto ED, Cramer MJ, Rutten FH, Onland-Moret NC, Ruijter HMD. Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions. BMC Med 2022;20:496.
8. Nishimura T, Senoo K, Makino M, et al. Prediction model for the new onset of atrial fibrillation combining features of 24-hour Holter electrocardiogram with 12-lead electrocardiogram. Int J Cardiol Heart Vasc 2023;47:101245.
9. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-7.
10. Santulli G, D’ascia SL, D’ascia C. Development of atrial fibrillation in recipients of cardiac resynchronization therapy: the role of atrial reverse remodelling. Can J Cardiol 2012;28:245.e17-8.
11. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-16.
12. Fleg JL. Diagnostic and prognostic value of stress testing in older persons. J Am Geriatr Soc 1995;43:190-4.
13. Correia LC, Lakatta EG, O’Connor FC, et al. Attenuated cardiovascular reserve during prolonged submaximal cycle exercise in healthy older subjects. J Am Coll Cardiol 2002;40:1290-7.
14. Groban L, Pailes NA, Bennett CD, et al. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol 2006;61:28-35.
15. Dai DF, Santana LF, Vermulst M, et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009;119:2789-97.
16. Basso N, Cini R, Pietrelli A, Ferder L, Terragno NA, Inserra F. Protective effect of long-term angiotensin II inhibition. Am J Physiol 2007;293:H1351-8.
17. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 2009;119:524-30.
18. Santulli G, Ciccarelli M, Trimarco B, Iaccarino G. Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system. Front Physiol 2013;4:209.
19. Stein M, Boulaksil M, Jansen JA, et al. Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol 2010;299:H310-21.
20. Elia A, Cannavo A, Gambino G, et al. Aging is associated with cardiac autonomic nerve fiber depletion and reduced cardiac and circulating BDNF levels. J Geriatr Cardiol 2021;18:549-59.
21. Feng N, Huke S, Zhu G, et al. Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation. Proc Natl Acad Sci USA 2015;112:1880-5.
22. Yang X, Zhang M, Xie B, et al. Myocardial brain-derived neurotrophic factor regulates cardiac bioenergetics through the transcription factor Yin Yang 1. Cardiovasc Res 2023;119:571-86.
23. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994;90:1225-38.
24. Santulli G, Iaccarino G. Adrenergic signaling in heart failure and cardiovascular aging. Maturitas 2016;93:65-72.
25. Santulli G, Iaccarino G. Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun Ageing 2013;10:10.
26. Perino A, Ghigo A, Ferrero E, et al. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol Cell 2011;42:84-95.
27. Nikolaev VO, Moshkov A, Lyon AR, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010;327:1653-7.
28. Lyon AR, Nikolaev VO, Miragoli M, et al. Plasticity of surface structures and β2-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail 2012;5:357-65.
29. Okumura S, Takagi G, Kawabe J, et al. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci USA 2003;100:9986-90.
30. Okumura S, Vatner DE, Kurotani R, et al. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation 2007;116:1776-83.
31. Yan L, Vatner DE, O’Connor, et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007;130:247-58.
32. Ciccarelli M, Chuprun JK, Rengo G, et al. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 2011;123:1953-62.
33. Ciccarelli M, Santulli G, Pascale V, Trimarco B, Iaccarino G. Adrenergic receptors and metabolism: role in development of cardiovascular disease. Front Physiol 2013;4:265.
35. Maslov MY, Chacko VP, Stuber M, et al. Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am J Physiol 2007;292:H387-91.
36. Schocke MF, Metzler B, Wolf C, et al. Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging 2003;21:553-9.
37. Remondino A, Kwon SH, Communal C, et al. β-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 2003;92:136-8.
38. No MH, Choi Y, Cho J, et al. Aging promotes mitochondria-mediated apoptosis in rat hearts. Life 2020;10:178.
39. Assali EA, Jones AE, Veliova M, et al. NCLX prevents cell death during adrenergic activation of the brown adipose tissue. Nat Commun 2020;11:3347.
40. Santulli G, Kansakar U, Varzideh F, Mone P, Jankauskas SS, Lombardi A. Functional role of taurine in aging and cardiovascular health: an updated overview. Nutrients 2023;15:4236.
41. Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat Rev Mol Cell Biol 2018;19:713-30.
42. Pekson R, Liang FG, Axelrod JL, et al. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore. Proc Natl Acad Sci USA 2023;120:e2303713120.
43. Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis 2017;1863:1066-77.
44. Zorova LD, Popkov VA, Plotnikov EY, et al. Mitochondrial membrane potential. Anal Biochem 2018;552:50-9.
45. Jedlička J, Tůma Z, Razak K, et al. Impact of aging on mitochondrial respiration in various organs. Physiol Res 2022;71:S227-36.
46. Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin 2012;8:143-64.
47. Ribeiro ASF, Zerolo BE, López-Espuela F, Sánchez R, Fernandes VS. Cardiac system during the aging process. Aging Dis 2023;14:1105-22.
48. Rysz J, Franczyk B, Rysz-Górzyńska M, Gluba-Brzózka A. Ageing, age-related cardiovascular risk and the beneficial role of natural components intake. Int J Mol Sci 2021;23:183.
49. Tocchi A, Quarles EK, Basisty N, Gitari L, Rabinovitch PS. Mitochondrial dysfunction in cardiac aging. Biochim Biophys Acta 2015;1847:1424-33.
50. Nanadikar MS, Vergel Leon AM, Guo J, et al. IDH3γ functions as a redox switch regulating mitochondrial energy metabolism and contractility in the heart. Nat Commun 2023;14:2123.
51. Shi X, Qiu H. New insights into energy substrate utilization and metabolic remodeling in cardiac physiological adaption. Front Physiol 2022;13:831829.
52. Gambardella J, Jankauskas SS, Kansakar U, et al. Ketone bodies rescue mitochondrial dysfunction via epigenetic remodeling. JACC Basic Transl Sci 2023;8:1123-37.
53. Liu Q, Pan S, Li P, Dixon RAF. Hippo pathway inhibition promotes metabolic adaptability and antioxidant response in myoblasts. Sci Rep 2023;13:2232.
54. Mone P, Morgante M, Pansini A, et al. Effects of insulin resistance on mitochondrial (dys)function. Atherosclerosis 2022;341:52-4.
55. Kane MS, Benavides GA, Osuma E, et al. The interplay between sex, time of day, fasting status, and their impact on cardiac mitochondrial structure, function, and dynamics. Sci Rep 2023;13:21638.
56. Hernandez-Resendiz S, Prakash A, Loo SJ, et al. Targeting mitochondrial shape: at the heart of cardioprotection. Basic Res Cardiol 2023;118:49.
57. Owesny P, Grune T. The link between obesity and aging - insights into cardiac energy metabolism. Mech Ageing Dev 2023;216:111870.
58. Boardman NT, Trani G, Scalabrin M, Romanello V, Wüst RCI. Intracellular to interorgan mitochondrial communication in striated muscle in health and disease. Endocr Rev 2023;44:668-92.
59. Fernando R, Shindyapina AV, Ost M, et al. Downregulation of mitochondrial metabolism is a driver for fast skeletal muscle loss during mouse aging. Commun Biol 2023;6:1240.
60. Santulli G, Monaco G, Parra V, Morciano G. Editorial: mitochondrial remodeling and dynamic inter-organellar contacts in cardiovascular physiopathology. Front Cell Dev Biol 2021;9:679725.
61. Parra V, Monaco G, Morciano G, Santulli G. Editorial: mitochondrial remodeling and dynamic inter-organellar contacts in cardiovascular physiopathology-volume II. Front Cell Dev Biol 2023;11:1240207.
62. Katti P, Love-Rutledge S, Murray SA, Hinton A Jr. Editorial: the role of mitochondrial endoplasmic reticulum contact sites in human health and disease. Front Mol Biosci 2023;10:1223354.
63. Santulli G, Lewis D, des Georges A, Marks AR, Frank J. Ryanodine receptor structure and function in health and disease. Subcell Biochem 2018;87:329-52.
64. Fernandez-Sanz C, Ruiz-Meana M, Miro-Casas E, et al. Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium. Cell Death Dis 2014;5:e1573.
66. Galizzi G, Di Carlo M. Insulin and its key role for mitochondrial function/dysfunction and quality control: a shared link between dysmetabolism and neurodegeneration. Biology 2022;11:943.
67. Cheng H, Gang X, He G, et al. The molecular mechanisms underlying mitochondria-associated endoplasmic reticulum membrane-induced insulin resistance. Front Endocrinol 2020;11:592129.
68. Peart JN, Pepe S, Reichelt ME, et al. Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium. Exp Gerontol 2014;50:72-81.
69. Mendoza A, Karch J. Keeping the beat against time: mitochondrial fitness in the aging heart. Front Aging 2022;3:951417.
70. Paolocci N, Biondi R, Bettini M, et al. Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart. J Mol Cell Cardiol 2001;33:671-9.
72. Jang S, Javadov S. Elucidating the contribution of ETC complexes I and II to the respirasome formation in cardiac mitochondria. Sci Rep 2018;8:17732.
73. Robb EL, Hall AR, Prime TA, et al. Control of mitochondrial superoxide production by reverse electron transport at complex I. J Biol Chem 2018;293:9869-79.
74. Zhao RZ, Jiang S, Zhang L, Yu ZB. Mitochondrial electron transport chain, ROS generation and uncoupling (review). Int J Mol Med 2019;44:3-15.
75. Kausar S, Wang F, Cui H. The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. Cells 2018;7:274.
76. Chaudhary P, Janmeda P, Docea AO, et al. Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. Front Chem 2023;11:1158198.
77. Jena AB, Samal RR, Bhol NK, Duttaroy AK. Cellular red-ox system in health and disease: the latest update. Biomed Pharmacother 2023;162:114606.
78. Hasanuzzaman M, Bhuyan MHMB, Zulfiqar F, et al. Reactive oxygen species and antioxidant defense in plants under abiotic stress: revisiting the crucial role of a universal defense regulator. Antioxidants 2020;9:681.
79. Gauthier LD, Greenstein JL, O’Rourke B, Winslow RL. An integrated mitochondrial ROS production and scavenging model: implications for heart failure. Biophys J 2013;105:2832-42.
80. Jomova K, Raptova R, Alomar SY, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 2023;97:2499-574.
81. Sharifi-Rad M, Anil Kumar NV, Zucca P, et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol 2020;11:694.
82. Snezhkina AV, Kudryavtseva AV, Kardymon OL, et al. ROS generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev 2019;2019:6175804.
83. Wang H, Liu C, Zhao Y, Gao G. Mitochondria regulation in ferroptosis. Eur J Cell Biol 2020;99:151058.
84. Rizvi F, Preston CC, Emelyanova L, et al. Effects of aging on cardiac oxidative stress and transcriptional changes in pathways of reactive oxygen species generation and clearance. J Am Heart Assoc 2021;10:e019948.
85. Napolitano G, Fasciolo G, Venditti P. Mitochondrial management of reactive oxygen species. Antioxidants 2021;10:1824.
86. Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 2001;276:23357-61.
87. Zorov DB, Popkov VA, Zorova LD, et al. Mitochondrial aging: is there a mitochondrial clock? J Gerontol A Biol Sci Med Sci 2017;72:1171-9.
88. Silachev DN, Plotnikov EY, Pevzner IB, et al. The mitochondrion as a key regulator of ischaemic tolerance and injury. Heart Lung Circ 2014;23:897-904.
89. Stanley BA, Sivakumaran V, Shi S, et al. Thioredoxin reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria. J Biol Chem 2011;286:33669-77.
90. Vue Z, Garza-Lopez E, Neikirk K, et al. 3D reconstruction of murine mitochondria reveals changes in structure during aging linked to the MICOS complex. Aging Cell 2023;22:e14009.
91. Warraich UE, Hussain F, Kayani HUR. Aging - oxidative stress, antioxidants and computational modeling. Heliyon 2020;6:e04107.
92. Checa J, Aran JM. Reactive Oxygen species: drivers of physiological and pathological processes. J Inflamm Res 2020;13:1057-73.
93. Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, Lipids and Proteins) and induced pathologies. Int J Mol Sci 2021;22:4642.
94. Anderson R, Richardson GD, Passos JF. Mechanisms driving the ageing heart. Exp Gerontol 2018;109:5-15.
95. Toba H, Lindsey ML. Extracellular matrix roles in cardiorenal fibrosis: potential therapeutic targets for CVD and CKD in the elderly. Pharmacol Ther 2019;193:99-120.
96. Umanskaya A, Santulli G, Xie W, Andersson DC, Reiken SR, Marks AR. Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging. Proc Natl Acad Sci USA 2014;111:15250-5.
97. Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci USA 2015;112:11389-94.
98. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005;308:1909-11.
99. Mao P, Manczak M, Calkins MJ, et al. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer’s disease: implications for neuroprotection and lifespan extension. Hum Mol Genet 2012;21:2973-90.
100. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010;12:503-35.
101. Cardoso AC, Lam NT, Savla JJ, et al. Mitochondrial substrate utilization regulates cardiomyocyte cell cycle progression. Nat Metab 2020;2:167-78.
102. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;1:642-5.
103. Druzhyna NM, Wilson GL, LeDoux SP. Mitochondrial DNA repair in aging and disease. Mech Ageing Dev 2008;129:383-90.
104. Gottlieb RA, Gustafsson AB. Mitochondrial turnover in the heart. Biochim Biophys Acta 2011;1813:1295-301.
105. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990;18:6927-33.
106. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 2005;19:419-21.
107. Ungvari Z, Orosz Z, Labinskyy N, et al. Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 2007;293:H37-47.
108. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 2018;15:505-22.
109. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 2010;65:1028-41.
110. Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res 2018;123:849-67.
111. Donato AJ, Black AD, Jablonski KL, Gano LB, Seals DR. Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell 2008;7:805-12.
112. Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 2015;21:677-87.
113. Bursch W, Ellinger A, Gerner C, Frohwein U, Schulte-Hermann, R. Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci 2000;926:1-12.
114. Orogo AM, Gustafsson ÅB. Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease. Circ Res 2015;116:489-503.
115. Xiong J, Luu TTT, Venkatachalam K, Du G, Zhu MX. Glutamine produces ammonium to tune lysosomal pH and regulate lysosomal function. Cells 2022;12:80.
116. Yin Z, Liu X, Ariosa A, et al. Psp2, a novel regulator of autophagy that promotes autophagy-related protein translation. Cell Res 2019;29:994-1008.
117. Ding WX, Yin XM. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem 2012;393:547-64.
119. Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005;68:355-65.
120. Sneve ML, Overbye A, Fengsrud M, Seglen PO. Comigration of two autophagosome-associated dehydrogenases on two-dimensional polyacrylamide gels. Autophagy 2005;1:157-62.
122. Majeski AE, Dice JF. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004;36:2435-44.
123. Santulli G. Cardioprotective effects of autophagy: eat your heart out, heart failure! Sci Transl Med 2018;10:eaau0462.
124. Bielawska M, Warszyńska M, Stefańska M, Błyszczuk P. Autophagy in heart failure: insights into mechanisms and therapeutic implications. J Cardiovasc Dev Dis 2023;10:352.
125. Santovito D, Steffens S, Barachini S, Madonna R. Autophagy, innate immunity, and cardiac disease. Front Cell Dev Biol 2023;11:1149409.
127. Sciarretta S, Boppana VS, Umapathi M, Frati G, Sadoshima J. Boosting autophagy in the diabetic heart: a translational perspective. Cardiovasc Diagn Ther 2015;5:394-402.
128. Kaludercic N, Maiuri MC, Kaushik S, et al. Comprehensive autophagy evaluation in cardiac disease models. Cardiovasc Res 2020;116:483-504.
129. Wang H, Wang L, Hu F, et al. Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway. Cardiovasc Diabetol 2022;21:205.
130. Pyo JO, Yoo SM, Ahn HH, et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun 2013;4:2300.
131. Bhuiyan MS, Pattison JS, Osinska H, et al. Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 2013;123:5284-97.
133. Hariharan N, Ikeda Y, Hong C, et al. Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One 2013;8:e51632.
134. Cao DJ, Jiang N, Blagg A, et al. Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy. J Am Heart Assoc 2013;2:e000016.
135. Yang YP, Liang ZQ, Gu ZL, Qin ZH. Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin 2005;26:1421-34.
136. Yuan Q, Chen Z, Santulli G, et al. Functional role of Calstabin2 in age-related cardiac alterations. Sci Rep 2014;4:7425.
137. Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 2015;125:25-32.
138. Dossou AS, Basu A. The Emerging Roles of mTORC1 in macromanaging autophagy. Cancers 2019;11:1422.
139. Deleyto-Seldas N, Efeyan A. The mTOR-autophagy axis and the control of metabolism. Front Cell Dev Biol 2021;9:655731.
140. Abdellatif M, Trummer-Herbst V, Heberle AM, et al. Fine-tuning cardiac insulin-like growth factor 1 receptor signaling to promote health and longevity. Circulation 2022;145:1853-66.
142. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010;141:290-303.
143. Santulli G, Totary-Jain H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics 2013;14:1517-26.
144. Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012;32:2-11.
145. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011;13:1016-23.
146. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat 2013;45:15-21.
147. Füllgrabe J, Klionsky DJ, Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol 2014;15:65-74.
148. Zhang Y, Wang X, Li XK, et al. Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice. Eur Heart J 2023;44:2746-59.
149. Packer M. Cardioprotective effects of Sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (sodium-glucose cotransporter 2) inhibitors. Circ Heart Fail 2020;13:e007197.
150. Alcendor RR, Gao S, Zhai P, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007;100:1512-21.
151. Peng J, Xiong J, Cui C, et al. Maternal eicosapentaenoic acid feeding decreases placental lipid deposition and improves the homeostasis of oxidative stress through a Sirtuin-1 (SIRT1) independent manner. Mol Nutr Food Res 2019;63:e1900343.
152. Karbasforooshan H, Karimi G. The role of SIRT1 in diabetic cardiomyopathy. Biomed Pharmacother 2017;90:386-92.
153. Hsu CP, Zhai P, Yamamoto T, et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010;122:2170-82.
154. Wang B, Yang Q, Sun YY, et al. Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J Cell Mol Med 2014;18:1599-611.
155. Bennett CF, Kaeberlein M. The mitochondrial unfolded protein response and increased longevity: cause, consequence, or correlation? Exp Gerontol 2014;56:142-6.
156. Weng H, Ma Y, Chen L, et al. A new vision of mitochondrial unfolded protein response to the sirtuin family. Curr Neuropharmacol 2020;18:613-23.
157. Ji T, Zhang X, Xin Z, et al. Does perturbation in the mitochondrial protein folding pave the way for neurodegeneration diseases? Ageing Res Rev 2020;57:100997.
158. Cilleros-Holgado P, Gómez-Fernández D, Piñero-Pérez R, et al. Mitochondrial quality control via mitochondrial unfolded protein response (mtUPR) in ageing and neurodegenerative diseases. Biomolecules 2023;13:1789.
159. Chen Q, Li L, Samidurai A, et al. Acute endoplasmic reticulum stress-induced mitochondria respiratory chain damage: the role of activated calpains. FASEB J 2024;38:e23404.
160. Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy. EMBO J 2021;40:e104705.
161. Siasos G, Tsigkou V, Kosmopoulos M, et al. Mitochondria and cardiovascular diseases-from pathophysiology to treatment. Ann Transl Med 2018;6:256.
162. Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med 2019;51:1-13.
163. Bhullar SK, Dhalla NS. Status of mitochondrial oxidative phosphorylation during the development of heart failure. Antioxidants 2023;12:1941.
164. Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN. The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Ann Med 2018;50:121-7.
165. Scheibye-knudsen M, Fang EF, Croteau DL, Wilson DM, Bohr VA. Protecting the mitochondrial powerhouse. Trends Cell Biology 2015;25:158-70.
166. Stamerra CA, Di Giosia P, Giorgini P, Ferri C, Sukhorukov VN, Sahebkar A. Mitochondrial dysfunction and cardiovascular disease: pathophysiology and emerging therapies. Oxid Med Cell Longev 2022;2022:9530007.
167. Kubli DA, Gustafsson ÅB. Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 2012;111:1208-21.
168. Liang W, Moyzis AG, Lampert MA, Diao RY, Najor RH, Gustafsson ÅB. Aging is associated with a decline in Atg9b-mediated autophagosome formation and appearance of enlarged mitochondria in the heart. Aging Cell 2020;19:e13187.
169. Wei X, Wu YE, Wang W, Zhang S, Liu D, Liu H. Decreased dynamin-related protein 1-related mitophagy induces myocardial apoptosis in the aging heart. Acta Biochim Biophys Sin 2021;53:1354-66.
170. Fernández-Ortiz M, Sayed RKA, Fernández-Martínez J, et al. Melatonin/Nrf2/NLRP3 connection in mouse heart mitochondria during aging. Antioxidants 2020;9:1187.
171. Lee Y, Lee HY, Hanna RA, Gustafsson ÅB. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol Heart Circ Physiol 2011;301:H1924-31.
172. Hamacher-Brady A, Brady NR, Logue SE, et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2007;14:146-57.
174. Wang Y, Xu Y, Guo W, et al. Ablation of Shank3 alleviates cardiac dysfunction in aging mice by promoting CaMKII activation and Parkin-mediated mitophagy. Redox Biol 2022;58:102537.
175. Shi R, Guberman M, Kirshenbaum LA. Mitochondrial quality control: the role of mitophagy in aging. Trends Cardiovasc Med 2018;28:246-60.
176. Jankauskas S, Kansakar U, De Donato A, Mone P, Varzideh F, Santulli G. Parkin controls cardiac function in obesity by regulating mitochondrial calcium uptake. JACC Basic Transl Sci 2022;7:797-9.
177. Zhu Q, Combs ME, Liu J, et al. GRAF1 integrates PINK1-Parkin signaling and actin dynamics to mediate cardiac mitochondrial homeostasis. Nat Commun 2023;14:8187.
178. Soh JEC, Shimizu A, Molla MR, et al. RhoA rescues cardiac senescence by regulating Parkin-mediated mitophagy. J Biol Chem 2023;299:102993.
179. LaRocca TJ, Hearon CM Jr, Henson GD, Seals DR. Mitochondrial quality control and age-associated arterial stiffening. Exp Gerontol 2014;58:78-82.
180. Kubli DA, Quinsay MN, Gustafsson AB. Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun Integr Biol 2013;6:e24511.
181. Huang W, Xie W, Zhong H, et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes acute liver injury induced by heat stroke. Front Immunol 2022;13:859231.
182. Billia F, Hauck L, Konecny F, Rao V, Shen J, Mak TW. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci USA 2011;108:9572-7.
183. Poznyak AV, Kirichenko TV, Borisov EE, Shakhpazyan NK, Kartuesov AG, Orekhov AN. Mitochondrial implications in cardiovascular aging and diseases: the specific role of mitochondrial dynamics and shifts. Int J Mol Sci 2022;23:2951.
184. Lu X, Gong Y, Hu W, et al. Ultrastructural and proteomic profiling of mitochondria-associated endoplasmic reticulum membranes reveal aging signatures in striated muscle. Cell Death Dis 2022;13:296.
185. Lozhkin A, Vendrov AE, Ramos-Mondragón R, et al. Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics. Redox Biol 2022;57:102474.
186. Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci 2001;114:867-74.
187. Di Nottia M, Verrigni D, Torraco A, Rizza T, Bertini E, Carrozzo R. Mitochondrial dynamics: molecular mechanisms, related primary mitochondrial disorders and therapeutic approaches. Genes 2021;12:247.
188. Zacharioudakis E, Biris N, Garner TP, et al. Direct small molecule activation of mitofusins. bioRxiv Forthcoming 2018.
189. Zerihun M, Sukumaran S, Qvit N. The Drp1-mediated mitochondrial fission protein interactome as an emerging core player in mitochondrial dynamics and cardiovascular disease therapy. Int J Mol Sci 2023;24:5785.
190. Ihenacho UK, Meacham KA, Harwig MC, Widlansky ME, Hill RB. Mitochondrial fission protein 1: emerging roles in organellar form and function in health and disease. Front Endocrinol 2021;12:660095.
191. Hu Q, Zhang H, Gutiérrez Cortés N, et al. Increased Drp1 acetylation by lipid overload induces cardiomyocyte death and heart dysfunction. Circ Res 2020;126:456-70.
192. Basu K, Lajoie D, Aumentado-Armstrong T, et al. Molecular mechanism of DRP1 assembly studied in vitro by cryo-electron microscopy. PLoS One 2017;12:e0179397.
193. Ljubicic V, Menzies KJ, Hood DA. Mitochondrial dysfunction is associated with a pro-apoptotic cellular environment in senescent cardiac muscle. Mech Ageing Dev 2010;131:79-88.
194. Breitzig MT, Alleyn MD, Lockey RF, Kolliputi N. A mitochondrial delicacy: dynamin-related protein 1 and mitochondrial dynamics. Am J Physiol Cell Physiol 2018;315:C80-90.
195. Piquereau J, Caffin F, Novotova M, et al. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc Res 2012;94:408-17.
196. Cahill TJ, Leo V, Kelly M, et al. Resistance of dynamin-related protein 1 oligomers to disassembly impairs mitophagy, resulting in myocardial inflammation and heart failure. J Biol Chem 2015;290:25907-19.
197. Li Z, Zhang Z, Ren Y, et al. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology 2021;22:165-87.
198. Zorov DB, Isaev NK, Plotnikov EY, et al. Perspectives of mitochondrial medicine. Biochemistry 2013;78:979-90.
199. Ramaccini D, Montoya-Uribe V, Aan FJ, et al. Mitochondrial function and dysfunction in dilated cardiomyopathy. Front Cell Dev Biol 2020;8:624216.
